ABSTRACT & COMMENTARY

The Zoster Vaccine Rapidly Loses Effectiveness in Adults Over 60

July 1, 2016

An observational study from Kaiser Permanente Southern California showed that while the shingles vaccine reduces the risk of herpes zoster, there is a major decline in effectiveness over just eight years in older adults.

Issue Date: July 1, 2016

Table of Contents

Infectious Disease Alert’s editor, Stan Deresinski, MD, FACP, FIDSA, reports no financial relationships relevant to this field of study; peer reviewer Patrick Joseph, MD, is laboratory director for Genomic Health, Siemens Corp., and CareDx; Updates author, Carol A. Kemper, MD, FACP, peer reviewer Kiran Gajurel, MD, continuing education and editorial director Lee Landenberger, executive editor Shelly Morrow Mark, and associate managing editor Jonathan Springston report no financial relationships to this field of study.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements